US 11327083
Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome
granted A61PA61P5/38
Quick answer
US patent 11327083 (Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome) held by Corcept Therapeutics Incorporated expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P5/38